REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120288472A1
SERIAL NO

13476183

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A mechanism of macrophage-induced T cell suppression is the selective elimination of tryptophan and/or increase in one or more tryptophan metabolites within the local macrophage microenvironment Expression of IDO can serve as a marker of suppression of T cell activation, and may play a significant role in allogeneic pregnancy and other types of transplantation. Inhibitors of IDO can be used to activate T cells. Inhibiting tryptophan degradation, or supplementing tryptophan concentration, can be used in addition to, or in place of, inhibitors of IDO. Increasing tryptophan degradation (thereby, decreasing tryptophan concentration and increasing tryptophan metabolite concentration), for example, by increasing IDO concentration or IDO activity, can suppress T cells. One can manipulate local tryptophan concentrations, and/or modulate the activity of the high affinity tryptophan transporter, and/or administer tryptophan degrading enzymes. Regulation can be further manipulated using cytokines such as MCSF, IFNγ, alone or in combination with antigen or other cytokines.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE1120 15TH STREET AUGUSTA GA 30912

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mellor, Andrew Augusta, US 20 337
MUNN, David Augusta, US 19 262

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation